Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache

详细信息    查看全文

• 作者：Pernilla Jonsson (1) Pernilla.Jonsson@socmed.gu.se
  Mattias Linde (234)
  Gunnel Hensing (1)
  Tove Hedenrud (1)
• 关键词：Headache &#8211 ; Medication ; overuse headache &#8211 ; Epidemiology &#8211 ; Educational status &#8211 ; Medication use &#8211 ; Health ; care contacts
• 刊名：The Journal of Headache and Pain
• 出版年：2012
• 出版时间：June 2012
• 年：2012
• 卷：13
• 期：4
• 页码：281-290
• 全文大小：250.2 KB
• 参考文献：1. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62(5):788–790
  2. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26(6):742–746
  3. Autret A, Roux S, Rimbaux-Lepage S, Valade D, Debiais S (2010) Psychopathology and quality of life burden in chronic daily headache: influence of migraine symptoms. J Headache Pain 11(3):247–253
  4. Colas R, Munoz P, Temprano R, Gomez C, Pascual J (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62(8):1338–1342
  5. Tenhunen K, Elander J (2005) A qualitative analysis of psychological processes mediating quality of life impairments in chronic daily headache. J Health Psychol 10(3):397–407
  6. Ferrari A, Coccia C, Sternieri E (2008) Past, present, and future prospects of medication-overuse headache classification. Headache 48(7):1096–1102
  7. Radat F, Lanteri-Minet M (2010) What is the role of dependence-related behavior in medication-overuse headache? Headache 50(10):1597–1611
  8. Saper JR, Lake AE 3rd (2006) Medication overuse headache: type I and type II. Cephalalgia 26(10):1262
  9. Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME (2006) Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 46(5):766–772
  10. Maizels M (2002) Health resource utilization of the emergency department headache “repeater”. Headache 42(8):747–753
  11. Pascual J, Colas R, Castillo J (2001) Epidemiology of chronic daily headache. Curr Pain Headache Rep 5(6):529–536
  12. Linde M, Dahlof C (2004) Attitudes and burden of disease among self-considered migraineurs: a nation-wide population-based survey in Sweden. Cephalalgia 24(6):455–465
  13. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ (1993) Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 20(2):131–137
  14. D’Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G (2005) Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache 45(5):553–560
  15. Atasoy HT, Unal AE, Atasoy N, Emre U, Sumer M (2005) Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache 45(1):25–31
  16. Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289–299
  17. Jonsson P, Hedenrud T, Linde M (2011) Epidemiology of medication overuse headache in Sweden. Cephalalgia 31(9):1015–1022
  18. Committee IHSHC (2004) The international classification of headache disorders, 2nd edition. Cephalalgia 24 (s1):1-160 doi: 10.1111/j.1468-2982.2003.00825.x
  19. Scher AI, Lipton RB, Stewart WF, Bigal M (2010) Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 30(3):321–328
  20. Peters M, Abu-Saad HH, Vydelingum V, Dowson A, Murphy M (2004) Migraine and chronic daily headache management: a qualitative study of patients’ perceptions. Scand J Caring Sci 18(3):294–303
  21. Ferrari A, Stefani M, Sternieri S, Bertolotti M, Sternieri E (1997) Analgesic drug taking: beliefs and behavior among headache patients. Headache 37(2):88–94
  22. MacGregor EA, Rosenberg JD, Kurth T (2011) Sex-related differences in epidemiological and clinic-based headache studies. Headache 51(6):843
  23. Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 44(11):1147–1157
  24. Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB (2003) The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 23(7):519–527
  25. Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M (1989) An epidemiologic study of headache among adolescents and young adults. JAMA 261(15):2211–2216
  26. Virtanen M, Kivim盲ki M, Vahtera J, Elovainio M, Sund R, Virtanen P, Ferrie JE (2006) Sickness absence as a risk factor for job termination, unemployment, and disability pension among temporary and permanent employees. Occup Environ Med 63(3):212
  27. Andersen A, Holstein BE, Due P, Hansen EH (2009) Medicine use for headache in adolescence predicts medicine use for headache in young adulthood. Pharmacoepidemiol Drug Saf 18(7):619–623
  28. Hagen K, Vatten L, Stovner LJ, Zwart JA, Krokstad S, Bovim G (2002) Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia 22(8):672–679
  29. Swedish Health Care Act (1982) Swedish Parliament
  30. Mattsson P, Tomson T, Eriksson O, Brannstrom L, Weitoft GR (2010) Sociodemographic differences in antiepileptic drug prescriptions to adult epilepsy patients. Neurology 74(4):295–301
  31. Straube A, Pfaffenrath V, Ladwig KH, Meisinger C, Hoffmann W, Fendrich K, Vennemann M, Berger K (2009) Prevalence of chronic migraine and medication overuse headache in Germany–the German DMKG headache study. Cephalalgia 30(2):207–213
  32. Hagen K, Zwart JA, Aamodt AH, Nilsen KB, Brathen G, Helde G, Stjern M, Tronvik EA, Stovner LJ (2010) The validity of questionnaire-based diagnoses: the third Nord-Trondelag Health Study 2006–2008. J Headache Pain 11(1):67–73
  33. Reijneveld SA, Stronks K (2001) The validity of self-reported use of health care across socioeconomic strata: a comparison of survey and registration data. Int J Epidemiol 30(6):1407–1414
  34. Pit SW, Byles JE, Cockburn J (2008) Accuracy of telephone self-report of drug use in older people and agreement with pharmaceutical claims data. Drugs Aging 25(1):71–80
• 作者单位：1. Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, P. O. Box 453, 405 30 Gothenburg, Sweden2. Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway3. Norwegian National Headache Centre, St. Olav鈥檚 University Hospital, Trondheim, Norway4. Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Pain Medicine
  Internal Medicine
  Neurology
  
• 出版者：Springer Milan
• ISSN：1129-2377

文摘

The objective of this study was to analyse sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache (MOH). A cross-sectional, population survey was conducted, in which 44,300 Swedes (≥15 years old) were interviewed over telephone. In total, 799 individuals had MOH. Of these, 47 % (n = 370) only used over-the-counter medications. During the last year, 46 % (n = 343) had made a headache-related visit to their physician and 14 % (n = 102) had visited a neurologist. Among individuals aged <30 years, the number of days/month with headache was greater than the number of days with medication use, whereas the opposite was true for those ≥30 years. Both the proportion using prophylactic medication and the proportion having consulted a neurologist were smaller among those who only had elementary school education than among those with higher education (p = 0.021 and p = 0.046). Those with a lower level of education also had a higher number of days/month with headache and with medication use than those with a higher educational level (p = 0.011 and p = 0.018). The MOH-sufferers have limited contacts with health-care and preventive measures thus need to include other actors as well. Particular efforts should be directed towards those with low educational levels, and more research on medication use in relation to age is required.